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Summary 
Introduction: Shiga toxin-producing Escherichia coli (STEC) are among the most important causes of food-
borne diseases. They cause illnesses ranging from mild diarrhea to more severe conditions that may progress 
to hemorrhagic colitis (HC) and hemolytic uremic syndrome (HUS). The burden of STEC in patients with 
diarrheal illness in Kitale county referral hospital, Trans-Nzoia County had not been established. 
Objectives: To determine the prevalence of STEC, its associated virulence genes and antimicrobial resistance 
among patients seeking treatment for diarrhoeal illness at Kitale County Referral Hospital. 
Methods: Stool samples from patients seeking treatment for diarrheal illness and had consented to participate 
in the study were collected and cultured for enteric bacteria.  
Suspect E.coli isolates were further identified using conventional biochemical methods. Conventional multiplex 
PCR targeting Shiga toxins (stx1, stx2, hlyA and attaching and effacing mechanisms (eaeA) were used to detect 
STEC virulence markers responsible for the Pathogenicity of STEC infection among other E.coli pathotypes. 
Results: A total of 295 participants were enrolled; median age 120 months (IQR: 36-312). 39 %( 115) were 
children aged <5yearsof whom 54% (160) were females. The prevalence of pathogenic E.coli was 19%56/295 
and STEC was the most prevalent among E.coli pathotypes at5.4%16/295.The Stx2 gene and the 
Stx1/Stx2/hlyAcombination were the most prevalent in the STEC strains. The virulence genes (Stx1, Stx2, eaeA* 
and HlyA*)were observed in 13, 19, 9 and 14 in STEC isolates respectively.The most common gene was Stx2 
and combinations of (Stx1+Stx2+hlyA)genes. Antimicrobial resistance to commonly prescribed antibiotics: 
chloramphenicol, ampicillin 10µg, erythromycin15µg, gentamicin10µg, ciprofloxacin 5µg, tetracycline 30µg, 
Trimethoprim/Sulfamethoxazole 25 µg, Cefotaxime 30 µg, furazolidine (8µg) and nalidixic acid 30 µg. were 
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observed for all E.coli isolates except one (1.8%; 95% CI=0.1-9.6%). No isolates among STEC showed 
resistance to Furazolidine drug. However, Trimethoprim / Sulphurmethoxazole) was the drug which exhibited 
the highest resistance at (94%, 95% CI 70 to 99%). 
Conclusion and recommendation: Prevalence of STEC was 5.4%, (Stx1/Stx2/hlyA) virulence genes combination 
was the most common. High resistance to commonly prescribed antibiotics were observed in E.coli isolates 
and may be an existing problem that needs to be further research investigation.  
KEY words: Shiga-ToxigenicEscherichia coli (STEC), antimicrobial resistance, Kitale County referral hospital. 
[Afr J Health Sci. 2017; 30(2):105-119] 
 
Introduction  
Diarrhoea is a significant health problem worldwide, 
especially in the developing world where adequate 
sanitation facilities are lacking [1]. Globally diarrheal 
diseases account for almost a fifth of all deaths of 
children below 5 years of age; with an estimated 2.2 
million deaths annually [2]. Shigatoxin-producing 
Escherichia coli (STEC) are rare pathogens but 
potentially fatal cause of gastroenteritis. They are 
associated with a wide spectrum of diseases ranging 
from mild to bloody diarrhoea, haemorrhagic colitis and 
a life threatening condition that progress to haemolytic 
uremic syndrome (HUS) that can be fatal [3]. Among 
several sero-groups of STEC, O157:H7 is the most 
pathogenic serotype associated with food-borne 
diseases [3, 4]. Domestic ruminants especially cattle are 
recognised as predominant reservoir of STEC [5, 6] 
,although this pathogen can be transmitted to humans 
directly through consumption of several foods of non-
bovine origin including unpasteurised juices, salami, 
cheese, raw(unpasteurised) milk contaminated food and 
water or indirectly through their environments [4, 7]. 
There is little information  about epidemiology  of  STEC 
in humans in Kenya, however some information on 
possible reservoirs for STEC have been described, 
including food products, healthy and diarrhoeagenic 
cattle, camels, and her ruminants [8-10]. Gastroenteritis 
caused by STEC strains has the capacity to produce 
cytotoxins similar to that produced by Shigella 
dysentriae type 1a study carried out among the Maasai 
community, in Narok and Kajiado districts showed STEC 
as one of the major causes of bloody diarrhoea at 
infection rate of 24.1% [12]. 
The primary STEC virulence factor responsible for the 
most serious outcomes of human infection is Shiga toxin 
(Stx), an AB5 toxin that targets cells expressing the 
Glycolipid-globo-triaosylceramide (Gb3) by disrupting 
host protein synthesis and causing apoptotic cell death 
[2]. Although the pathogenicity mechanisms of STEC 
are not yet fully understood, Shiga toxin genes 1 and 2 
(Stx1and Stx2) are the main factors for virulence 
properties in STEC pathogenesis and development of 
clinical symptoms [12]  
Other virulence factors may play significant roles in the 
pathogenicity of this pathogen such as intimin which is 
encoded by the chromosomal gene eaeA and is 
responsible for intimate attachment of STEC to intestinal 
epithelial cells [13]. Since cows have been incriminated 
as the  primary hosts of STEC and especially serotype 
O157:H7,Trans -Nzoia County  has a potential of  
STEC presence due to both dairy and beef farming  
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which entails  human contacts with animals thus  poses 
a threat on outbreaks of  human illnesses due to STEC. 
Recently, several reports have documented a significant 
increase in antimicrobial resistance in STEC strains [14, 
15]. Inappropriate usages of antibiotics for treating 
human and plant diseases and for promoting food-
animal growth have been proposed to contribute to 
antimicrobial resistance among bacteria population [16, 
17]. Moreover, the use of antimicrobials agents to treat 
STEC infections is contravasials since they can induce 
Shigatoxin (Stx) production resulting in HUS in human 
[18, 19]. STEC strains have been recovered from a 
variety of animals, and cattle are considered the major 
reservoir for STEC strains [20-22]. Small domestic 
ruminants are also relevant STEC reservoirs that could 
potentially be transmitted to humans, thru direct or 
indirect contact, or via the food chain [23]. In addition, 
the present study examined antimicrobial resistance 
patterns of all pathogenic E.coli isolated from the 
diarrheal patients from the study site in order to gauge 
the effectiveness of commonly available antimicrobials. 
Therefore, due to the importance of STEC in human 
health, this study sought to address the prevalence of 
STEC, its virulence gene profiles and antimicrobial 
resistance among patients treated with diarrhoea illness 
in Kitale County referral hospital, Trans-Nzoia County. 
 
Materials and Methods 
Study design: This was hospital based cross-sectional 
study carried out between August 2015 and June 2016 
that aimed to provide prevalence of STEC its associated 
virulence genes and antimicrobial susceptibility from 
patients of all ages that sought  treatment for diarrhoea 
illness at Kitale County Referral Hospital, Trans-Nzoia 
County. 
 
Study site and population: The study was carried out 
at Kitale County hospital situated in Trans-Nzoia County 
which is located in the North Rift bordering West Pokot 
County to the North, Elgeyo - Marakwet County to the 
East, Bungoma County to the West and Uasin-Gishu 
County to South. The hospital was selected because it 
has recorded high rates of childhood morbidity and 
mortality due to bloody diarrhea (hospital records).  
Kitale hospital serves a population of about 106,187 
according to the Census report in 2009 and of who most 
are livestock farmers and milk vendors and being a 
cosmopolitan town. This is an ideal target population 
that favors transmission and infectionfor STEC.The 
target population included patients of all ages seeking 
treatment in Kitale County hospital, presenting with 
acute diarrheal illness (3 or more passages of loose or 
watery stool within 24 hrs) and willing to participate were 
recruited and enrolled into the study. 
Inclusion criteria: All out patients of all ages who 
sought treatment for diarrheal illness at Kitale County 
hospital and were willing to consent/assent for children 
to participate in the study were recruited. 
Exclusion criteria: Patients who had taken antibiotics 
within 72hrs of symptom onset and those who were 
unwilling to participate or give stool samples. Those 
who declined to participate in the study were also 
excluded.  
 
Collection of stool sample 
A total of 295 Stool samples were collected from 
patients with diarrheal illness in sterile containers and 
transferred into Cary Blair transport medium at room 
temperature and packaged following the triple packaging 
system [24] and sent to KEMRI Centre for microbiology 
for processing. All the samples were plated onto 
differential media, Sorbital-MacConkey for detection of 
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O157 (STEC) and MacConkey to screen for other E. 
coli. Thereafter, plates were then incubated at 35ºC - 
37ºC for 18-24 hours. 
After an overnight incubation approximately five to ten 
pink colonies with a darker centre from MacConkey and 
colourless colonies from Sorbital- MacConkey were 
picked and subjected to biochemical test using standard 
method. Confirmed E.coli colonies were further cultured 
onto nutrient agar and incubated for 18-24 hours at 
37ºC for PCR analysis [25]. 
Control and clinical E.coli strains 
Control E.coli strain O157:H7 which harbours (Vt1, Vt2, 
hlyA and intimin genes (eaeA) was used as a standard 
and clinical E.coli isolates isolated from stool were used 
for preparation of DNA templates for PCR. Single colony 
from each plate was picked using sterile applicator sticks 
and mixed with 25µl of distilled water in a micro 
centrifuge tube. Only 2.0 µl of this suspension was used 
as template for the PCR [26]. 
Primers 
Primer set for amplifying segments of the Shiga toxins 
(Vt1, Vt2, hlyA and intimin genes (eaeA) of attaching and 
effacing mechanisms), cytotoxic necrotising factors1&2 
(CNFI) and (CNF2) Enteroaggregative mechanism 
(Eagg), enteroinvasive mechanism (Einves), and heat-
labile (LT) and heat-stable (ST1 ad ST2) toxins was 
tested using the method described [26]. Multiplex PCR 
primer sequence and the size of the PCR products of 
each set of primers used in this study are listed in (table 
1). The primers were selected based on the specificity 
and sensitivity and also based on the PCR product size 
distinguishable by the agarose gel electrophoresis in 
multiplex PCR systems from different studies. 
 
Table1.Primers used for PCR and DNA sequencing described. 
DEC Group Virulence Factor Primer sequence 5–3ˊ Product size 
 
 
 
 
STEC 
Vt1 
 
fp:5´- ACGTTACAGCGTGTTGCRGGGATC-3´ 
rp:5´-TTGCCACAGACTGCGTCAGTRAGG-3´ 
121 [26] 
Vt2 
  
fp:5´-TGTGTCTGGGTTCGTTAATACGGC-3´ 
rp:5´-TCCGTTGTCATGGAAACCGTTGTC-3´ 
102[26] 
hlyA 
 
fp:5´-AGCTGCAAGTGCGGGTCTG-3´ 
rp:5´TACGGGTTATGCCTGCAAGTTCAC -3´ 
569 [27] 
EPEC eaeA fp:5´-TGAGCGGCTGGCATGAGTCATAC-3´ 
rp:5´TCGATCCCCATCGTCACCAGAGG-3´ 
482 [28] 
EAGG     
 
Eagg fp:5´-AGACTCTGGCGAAAGACTGTATC-3´ 
rp:5´-ATGGCTGTCTGTAATAGATGAGAAC-3´ 
194 [26] 
EIEC Einv fp:5´-TGGAAAAACTCAGTGCCTCTGCGG-3´ 
rp:5´-TTCTGATGCCTGATGGACCAGGAG-3´ 
140 [26] 
 
 
ETEC              
ST1 fp:5´TTTCCCCTCTTTTAGTCACTCAACTG3´ 
rp:5´-GGCAGGATTACAACAAAGTTCACAG-3´ 
160 [26] 
ST2 fp:5´-CCCCCTCTCTTTTGCACTTCTTTCC-3´ 
rp:5´-TGCTCCAGCAGTACCATCTAACCC-3´ 
423 [26] 
 Lt1 fp:5´-TGGATTCATCATGCACCACAAGG-3´ 
rp:5´-CCATTTCTCTTTTGCCTGCCATC-3´ 
360 [26] 
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Colony PCR, Single and multiplex 
Amplification reactions were performed in a reaction 
volume of 25µl. The DNA template of 2µl of bacterial 
suspension was added to a master mix containing2.5 
μL of 10× PCR buffer, 0.5mM MgCl2, 250 Mm dNTPs, 
1 μM of each primer and 0.5 μL Dream Taq DNA 
polymerase. The thermo cycling conditions for all the 
PCRs were as follows: 94 °C for 5 min for initial 
denaturation and 30 cycles of 95 °C for 30 s 
(denaturation), 52 °C for 1 min and 72 °C for 1 min 30 
s (extension), followed by 72 °C for 10 min (final 
extension) and all the PCRs were performed in 0.2ml 
Eppendorf tubes in the MJ Research PTC-200 Thermal 
Cycler.  
Amplified PCR products were separated and visualised 
by 100μL of 1%agarose gel electrophoresis in the final 
mixture Tris-acetate-EDTA buffer containing0.5 mg 
EtBr staining. To determine molecular weight, 100–
1,000 bp DNA ladder (Fermentas) was used. 
Antibiotic Susceptibility Testing 
Antimicrobial resistance patterns of E. coli pathotypes 
were done using the disk diffusion technique of Kirby-
Bauer determination of the antimicrobial resistance 
profile; the isolated colonies from overnight growth on 
nutrient agar medium were emulsified in 3ml of sterile 
distilled water to achieve the correct turbidity that 
matched that of 0.5 McFarland standards and was used 
within 15 minutes. The drug susceptibility was done 
against the following Antibiotics: chloramphenicol (30 
μg), ampicillin 10µg, erythromycin15µg, 
gentamicin10µg, ciprofloxacin 5µg, tetracycline 30µg, 
Trimethoprim/Sulfamethoxazole 25 µg, Cefotaxime 30 
µg, furazolidine6µg and nalidixic acid 30 µg. The zones’ 
inhibition was interpreted using CLS standards 
guidelines [29] using E. coli (ATCC 25922) as a quality 
control strain for drug susceptibility testing. 
 
Statistical analysis 
With a prevalence of STEC of 24.1% [12], level of 
significance of 0.05, a sample size of at least 277 
participants was adequate for the study [30].  
Prevalence of STEC was computed as proportion of all 
the study participants, its associated virulence genes 
and antimicrobial resistance were computed as 
proportion of participants with an isolate with 95% 
binomial exact confidence intervals. Age of the 
participants was grouped into 3 categories; <5 (pre-
school going age), 5-18 (school going age and 
adolescents) and ≥18 years (adults) as is commonly 
stratified.  
 
Ethical considerations 
This study was approved by KEMRI ethical review 
committee (KEMRI/SERU/CMR/P0016/3094) and also 
by the University Board.  All study participants gave 
written consent and assent before inclusion. 
 
Results 
Demographic characteristics of the participants 
Participants age range between 1 ̶̶ 804 months and 
(medial=120, IQR=36 ̶̶ 312) months with majority (39%; 
n=115/295) being children< 5years (pre-school going 
age), 18% were aged between 5-18 years (school 
going age and adolescents) and 43% of the participants 
were above 18 years (adults) respectively. One hundred 
and sixty (54%) of all the participants were female. 
Distribution of participants in gender groups was fairly 
random (Table 1).  
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Table1.Distribution of E.coli pathotypes based on Gender and Age 
No. Of participants N=295 (%) Any E.coli Pathotypes (N=56) STEC Pathotypes (n=20) 
Gender 
Male 
Female 
135 (46) 
160 (54) 
24 (43) 
32 (57) 
8 (40) 
12 (60) 
p-value 0.62 0.68 
Age                 
<5years 
5 to 18 years 
≥ 18years 
116 (39) 
54 (18) 
126 (43) 
24 (43) 
11 (20) 
21 (38) 
9 (45) 
3 (15) 
8 (40) 
                                     p- value 0.70 0.84 
STEC- Shigatoxigenic Escherichia coli 
Prevalence of Pathogenic E.coli. 
The overall prevalence of Pathogenic E.coli was 19% 
(n=56; 95% CI=15 ̶̶ 24%).From a total of 20 E.coli 
isolates STEC was identified   as follows; 16 STEC only, 
3 STEC/Eagg and 1 STEC/ETEC combination. The 
prevalence of only STEC, STEC/Eagg and STEC/ETEC 
infections were 5.4% (95% CI= 3.1 ̶̶ 8.7%), 1.3%, (95% 
CI= 0.2 ̶̶ 2.9%) and 0.3%, (95% CI=0.006 ̶̶ 1.9%) 
respectively (Figure1). 
The overall distribution of the Pathogenic E.coli did not 
differ by gender (P=0.62) or age (0.34) groups similar 
to the distribution of STEC Pathotypes (p=0.59 and P= 
0.68 respectively). 
Figure.1 Prevalence of various E.coli pathotypes isolated from diarrheal patients. 
 
 
 
 Prevalence of E coli pathotypes 
E coli 
Pathotypes 
 
n 
 Prevalence 
 95% CI. 
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Table legend figure 1. 
 
At 95% Confidence Interval. 
 
Distribution of virulence genes indifferent E.coli 
pathotypes 
Virulence genes were distributed among 56 isolates of 
pathogenic E.coli, identified in various isolates as 
follows; Thirty four isolates (12) had one, 6 (2.0) two 12 
(4.1) three, 3 (1.0) four and 1 (0.3) five virulence genes 
respectively.Stx2gene was the most common gene at 
19% (95 CI= 12-28%) while Lt was the least common 
gene observed at 8.1% 95% CI=3.6-15). 
Of the 20 STEC isolates, a total of 55 virulence genes 
were identified and different virulence genes 
combinations of STEC were as 
follows;Stx1/Stx2/hlyA(n=7), was the most common 
combination followed by Stx1/Stx2/ hlyA/ eaeA (n=3). 
Stx1/ Stx2/ eaeA, Stx2/ hlyA, Stx2/ eaeA and Stx2/hlyA/ 
eaeA combinations were each observed in 2 isolates,  
Only Stx1 or Stx2were each observed in one isolates 
while Stx1/ hlyA, Stx1/ eaeA, Stx1/ hlyA/ eaeA and Stx1/ 
Stx2 combinations were not observed in any isolates 
(Table 2). 
Table 2: Shiga-toxin producing Escherichia coli isolate virulence gene profiles  
 
Virulence genes combinations observed No. Of STEC isolates N=20 (%) 
Stx1 1 (5) 
Stx1/ eaeA* 0 
Stx1/ hlyA* 0 
Stx1/ hlyA / eaeA 0 
Stx2 1 (5) 
Stx2/ eaeA 2 (10) 
Stx2/ hlyA 2 (10) 
Stx2/ hlyA / eaeA 2 (10) 
Stx1/ Stx2 0 
Stx1/ Stx2/ eaeA 2 (10) 
Stx1/Stx2/hlyA 7 (35) 
Stx1/Stx2/ hlyA / eaeA 3 (15) 
*The detection of these virulence factors was carried out only in samples positive for Stx1, Stx2or both Stx1and Stx2 
  
Lower limit Prevalence  Upper limit 
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Antimicrobial resistance patterns of pathogenic 
E.coli isolates 
A total of 56 isolates were tested for antimicrobial 
resistance against 10 drugs and analysis showed that 
pathogenic E.coli had highest resistance to STX at 
89%of over 75% to Erythromycin (ERY) and 
trimethoprim/Sulphurmethoxazole (STX). Among these 
isolates only 1/56 (1.8%, 95% CI 0.1 to 9.6%) was 
susceptible and the remaining 55 isolates showed 
resistance to all the 10 antibiotics tested. Of these 
36/55 (65%, 95% CI= 51 to 78%) isolates were 
resistant to at least one drug, 19/55 isolates had 
resistance to <5 drugs. with one isolate showing high 
levels of resistance to 9 drugs tested. Among the STEC 
isolates, most resistance was observed to Trimethoprim/ 
Sulphurmethoxazole antibiotics 15/16 (94%, 95% CI 70 
to 99%) while none showed resistance to Furazolidine 
(Figure 2b). Overall, trimethoprim/ Sulphurmethoxazole 
was the most resistance drug 50/56 (89%, 95% CI 78 
to 96%) while Ciprofloxacin showed the least resistance 
3/56 (5.3%, 95% CI 1.1 to 15%) (Figure2a)
Figure 2: Antimicrobial resistance patterns to commonly prescribed antibiotics (a) Overall resistance in all E 
coli pathotypes isolated (b) Over resistance in STEC isolates. 
  
*KEY: (AMP-Ampicillin, CHL-Chloramphenicol, CIP- 
Ciprofloxacin, TET-Tetracycline, NAL Nalidixic acid, 
FUR- Furazolidine, CN- Gentamicin, ERY-
Erythromycin, TX-Cefotaxime, STX-
Trimethoprim/Sulphurmethoxazole) 
Discussion 
The present study shows the prevalence associated 
virulence genes and antimicrobial resistance patterns of 
STEC from patients of all ages seeking treatment for 
diarrheal illness, in Trans-Nzoia County, Kenya. 
Virulence factors associated with E. coli pathotypes in 
the County have also been highlighted.  
In the 295 participants, the overall prevalence of 
Pathogenic E.coli was 19% (n=56; 95% CI=15 ̶̶ 24%). 
STEC was the most frequently (5.4%) identified 
potential E. coli pathogen and a major cause of acute 
illness and cases of HUS as compared to other 
pathogens of a food-borne transmission component. 
EAEC at 4% (n=13) was the second most prevalent 
cause of diarrhoea followed by ETEC at 2.7% (n=8) 
while EPEC and EIEC both at (2.4%) were the least 
prevalent E. coli pathotypes in our study (figure 1). 
Although STEC outcome range from mild intestinal 
discomfort, to haemolytic Uremic syndrome (HUS), end-
stage renal disease and death [31, 32] although the 
(b) (a) 
 113 
African Journal of Health Sciences, Volume 30, Number 2, March-April 2017 
reported incidences is often low, larger outbreaks with 
serious consequences occur [33].  These are severe 
sequelae that must be accounted for when prioritizing 
food borne pathogens for control efforts. As expected 
we observed a relatively higher STEC prevalence than 
those which have been reported in many developed 
countries including Switzerland 1% [34], Germany 1% 
[35], Belgium 0.2% [36] and 3% [37] France, and urban 
parts of Kenya such as Nairobi where a prevalence of 
0.97% [38] and 0.8% [11] have been reported. Kitale is 
relatively rural area and the inhabitants mainly obtain 
most of its water from River Nzoia, which crosses 
densely populated farmlands of Trans Nzoia possibly 
carrying along large amounts of agricultural and 
domestic waste, which is presumably checked by the 
treatment process at Nzoia Water treatment plant also 
rely on untreated water from boreholes, springs wells 
and river for domestic use, bacterial contamination in 
Kitale is 77.3% [39]. However the STEC prevalence in 
in this study was lower than reports from Maasai land; 
where STEC prevalence of up to 24.1% has been 
reported [12]. The Maasai community are pastoralists 
famous for consumption of raw meat and milk whereas 
STEC strains have been recovered from a variety of 
animals, and cattle are considered the major reservoir 
for STEC strains [20, 21]. Recent evidence has 
indicated that small domestic ruminants are also 
relevant STEC reservoirs [22, 23].   
Though there was no significant difference in distribution 
of STEC by age (P=0.34), the prevalence was highest 
(39%) in children < 5years (table 1). STEC has been 
reported to be more frequent and its impact more severe 
in young children from developed countries [40-43]. In 
less developed countries where childhood diarrhoeal 
diseases are more endemic, studies typically focus 
solely on children but have also identified STEC as a 
pathogen of concern in this age group [44-47], although 
our study cuts across all age groups majority of the 
study participants being children. The overall distribution 
of the Pathogenic E.coli did not differ by gender 
(P=0.62) or age groups (p= 0.34) similar to the 
distribution of STEC Pathotypes (p=0.59 and P= 0.68) 
this shows that both age and gender are not risk factors 
for E.coli infection in Kitale. 
Studies from different geographical areas show different 
pattern of E coli pathotypes. In Kenya Sang reported 
EAEC (8.9%), as the most frequent followed by ETEC 
(1.2%) and EIEC (0.6%) among the Maasai community 
[12] while among the Maasai community ETEC (29.8%) 
was the most prevalent followed by STEC (24%), EAEC 
(14.2%) then EPEC (3.5%) [1]. From an urban 
community in Nairobi, [38] identified EPEC (19.3%) as 
the most prevalent followed by ETEC (7.25%); EAEC 
(3.86%) and STEC (0.97%) while [38] observed EAEC 
as the most frequent E coli pathotype (36.6%) in 
diarrhoeagenic Escherichia coli isolates from children < 
5 years from Kenya and Japan. In Tanzania country, 
EAEC (64.1%) was the most detected followed by 
EPEC (20.3%) then ETEC (15.6%) [48]. These 
differences in prevalence of E coli pathotypes in different 
geographical areas could be explained by the different 
social behavioural, life styles and cultural practises in 
the communities. For instance the Maasai community in 
the savannah of Narok where major national parks: 
Maasai Mara and Amboseli are located these 
communities in savannah areas practice  open field 
defecation  and also share same water points with their 
domestic animals and wild animals. [12, 49] they all 
observed EAEC as the most prevalent E.coli pathotype. 
Multiple infections with STEC/EAEC and STEC/ETEC 
were observed in 3 and 1 isolates respectively. This was 
quite unique for our isolates as no study in Kenya has 
reported multiple infections of STEC and other E.coli 
pathotypes in diarrhoea isolates. The varying 
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combination of multiple virulence genes harboured by 
the STEC/ EAEC is a rarer pathotypes that harbours the 
phage-mediated Shiga toxin determinant with an 
Enteroaggregative gene while the STEC/ETEC isolates 
showed that the strains were a mixture of several 
different E. coli pathogroup-associated properties. In 
addition, these strains (STEC/EAEC and STEC/ETEC) 
harboured other virulence genes, some of which have 
been associated with ETEC, STEC, and EAEC.  
In this study, the most observed virulence genes in 
different E.coli pathotypes was Stx2 gene at 19% while 
Lt gene was the least common gene at 8.1%. Among 
the 20 STEC isolates, stx2 gene was observed most at 
6.4% and the most common virulence genes 
combination observed was Stx1/Stx2/hlyA at 35%.3 
(15%) of the isolates were positive for all the four 
virulence genes (stx1+stx2+hylA+eaeA) that are 
responsible for STEC infection. An accessory genes 
(eaeA n=9 and hlyA n=14) were detected only in 
isolates positive for Stx1, Stx2or both Stx1and Stx2 (table 
2). These finding concur with other studies done 
elsewhere. Epidemiological studies have revealed that 
stx2 is more associated with severe human disease (HC 
and HUS) than stx1 [50, 5].  
However other studies observe a slight difference in 
gene combination. In Kenya, in 2012 Sang  observed 
stx1+stx2and stx1 as the most prevalent, while [51] in 
India i an overall uneven distribution of all the three 
virulence genes in the STEC strains isolated from food 
samples, indicating the most isolated genes as stx1and 
stx1+stx2combination.Virulence genes make E. coli 
pathogens capable of causing disease and Shigatoxin-
producing E. coli (STEC or EHEC) with shiga-like toxin 
production by the Stx1 , Stx2and eaeA, genes are 
considered the most virulent [52, 53]. Worldwide 
epidemiological studies show that not all the strains 
producing Shigatoxin are pathogenic; it is believed that 
accessory genes may be responsible for or contribute to 
human pathogenic state [54-5]). 
Although Shigatoxin production is essential but not 
sufficient for STEC virulence, dual existence of multiple 
virulence genes in combination viz-a-viz single gene in 
this study raises questions as to whether or not these 
genes act in synergy to produce to induce acute 
disease. In this study most isolates exhibited multiple 
virulent gene combination demonstrating that STEC is 
among significant causes of gastroenteritis in the region. 
Enterohaemolysin liberates hemoglobin from the RBCs 
and is linked to the severity of the disease. It is widely 
accepted that E. coli strains harboring both stx and hlyA 
may pose a higher risk to human health [5].  
The study also investigated the prevalence and 
Antimicrobial resistance profiles of pathogenic E.coli and 
the results identified an overall resistance of over 75% 
to commonly prescribed drugs (AMP), (ERY) and (STX). 
A total of 36/55 (65%), isolates showed resistance to at 
least one of the commonly prescribed antibiotics , 19/55 
isolates had resistance to <5 drugs and only one isolate 
showed highest resistance to all the 9 commonly 
prescribed antibiotics in the country tested in this study 
(figure 3a). Overall, Trimethoprim/ Sulphurmethoxazole 
was the most resistant drug 50/56 (89%, 95% CI 78 to 
96%) while Ciprofloxacin was least resistant drug 3/56 
(5.3%, 95% CI 1.1 to 15%).Most studies have 
confirmed emergence of antibiotics resistance in 
Bacterial organisms. A study on commensal gut flora 
from children in Sudan found that 39% of children had 
strains resistant to six antimicrobial agents and over 
70% of the children had strains resistant to at least 4 of 
6 antimicrobial agents commonly prescribed in the 
country [58]. Multiple antimicrobial resistances among 
strains of pathogenic E. coli have also been reported in 
Kenya [48, 59, 60]. This is most likely to have been 
attributed by increased in the widespread use of 
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antimicrobial agents diminishes the efficacy of affordable 
and available drugs [61]. The emergence and spread of 
antimicrobial resistance in bacteria of medical 
importance imposes serious constraints on the options 
available for treatment of many infections.  
Among the STEC isolates, Trimethoprim/ 
Sulphurmethoxazole was the most resistant drug 15/16 
(94%, 95% CI 70 to 99%) however, none of the STEC 
isolates showed resistant to Furazolidine (figure 3b). 
Generally, the resistance rates observed in this study 
were much lower for Ampicillin, Tetracycline and 
Chloramphenicol. Although the results from this study 
indicated that all isolates were susceptible to 
furazolidine while Cefotaxime and ciprofloxacin had low 
resistance levels, chromosomal resistance to these 
agents could be easily transferred. Although previous 
studies showed moderate activity against STEC E. coli 
strains for Tetracycline and Chloramphenicol [59]. This 
study points out a rising prevalence of antimicrobial 
resistance among pathogenic E. coli isolates from Trans 
Nzoia County. Emerging resistance to third generation 
cephalosporin’s (Gentamicin at 18% and ciprofloxacin 
at 5.4%) and quinolones (nalidixic acid at 39%) was 
observed in this study highlighting the significance of 
antimicrobial resistance. This rapid emergence of 
antimicrobial resistance could be attributable to change 
in life style, introduction of new activities in the region, 
climatic changes and increased human traffic. 
 
Conclusion and recommendation 
Although STEC infection has not attracted much 
attention as a medical problem in Kenya, this study 
finding demonstrates the presence of the STEC at the 
rate of 5.4% in Kitale. The most common Virulence 
genes combination associated with the isolates was 
Stx1/Stx2/hlyA and Stx1/Stx2/hlyA/eaeA the 
combinations responsible for enterohaemorrhagic E coli 
infections. High antimicrobial resistance of up to 75% to 
commonly prescribed antibiotics including emerging 
resistance to 3rd generation cephalosporin’s and 
quinolones were observed.  
We highlight STEC infection not only an existing 
problem in Kitale but also an escalated problem 
considering the high/emerging antimicrobial and 
resistance observed. These necessitate further and 
immediate investigation to identify reservoirs and 
potential sources of STEC in order to establish control 
and prevention strategies for STEC associated diseases 
in humans. Early recognition of the problem, as well as 
appropriate treatment and improvement of hygiene may 
be beneficial in increasing survival rates.  
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